Concepedia
Statistics
Publications
18
Citations
1K
H-Index
14
Active since
1996
Affiliations
Johnson & Johnson (United States)(Current)
Janssen (United States)
The University of Texas at Austin
Richard L. Apodaca is an author at Johnson & Johnson (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1996–2016
Direct Reductive Amination of Aldehydes and Ketones Using Phenylsilane: Catalysis by Dibutyltin Dichloride
Richard L. Apodaca, Wei Xiao · Organic Letters · 2001 · 163 citations
Natural Sciences, Chemistry, Catalysis +6
Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H<sub>3</sub> antagonist
Ann Barbier, Craig W. Berridge, Christine Dugovic et al. · British Journal of Pharmacology · 2004 · 143 citations · Full text
Medicine, Neuroscience, Pharmacology +16
A New Class of Diamine-Based Human Histamine H<sub>3</sub> Receptor Antagonists: 4-(Aminoalkoxy)benzylamines
Richard L. Apodaca, Curt A. Dvorak, Wei Xiao et al. · Journal of Medicinal Chemistry · 2003 · 119 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
John M. Keith, Richard L. Apodaca, Wei Xiao et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 92 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +8
Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase
Mark J. Karbarz, Lin Luo, Leon Chang et al. · Anesthesia & Analgesia · 2008 · 74 citations
Life Sciences, Biochemistry, Pharmacology +13
1–5 of 18